Skip to main content
SpringerLink
Log in

BAYo1248: and BAYm1099 both result in increased insulin effectiveness and improved postprandial glucose tolerance in these diabetic patients

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

BAYo1248: and BAYm1099 both result in increased insulin effectiveness and improved postprandial glucose tolerance in these diabetic patients. Inpharma Wkly. 558, 4–5 (1986). https://doi.org/10.1007/BF03307395

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03307395

Keywords

Search

Navigation